Miles of

Displaying listings from all locations.

Use the fields below to filter listings for a particular country, city, or state. Start by selecting the top most region, the other fields will be automatically updated to show available locations.

Use the Clear Filter button if you want to start over.

CRBP

Sort By: RatingRating CountBusiness NameZIP Code
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile
500 River Ridge Drive
Second Floor
Norwood, MA United States
02062
(0)
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company’s lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in clinical studies in systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus erythematosus.

 

Click Here To Visit
CRBP
Back to top button
Close
Close